Erschienen in:
25.01.2022 | Letter to the Editor
Reassessment of Confidence in a Network Meta-analysis of Antidysrhythmic Drugs for Atrial Fibrillation Cardioversion
verfasst von:
Ian S. deSouza, Robert Allen, Pragati Shrestha
Erschienen in:
Cardiovascular Drugs and Therapy
|
Ausgabe 6/2022
Einloggen, um Zugang zu erhalten
Excerpt
We read with interest the network meta-analysis (NMA) by Tsiachris et al. [
1] that sought to compare and rank antidysrhythmic drugs for cardioversion of paroxysmal atrial fibrillation (AF). We congratulate the group for such an undertaking but also feel compelled to discuss additional limitations. To improve the power of their analyses, Tsiachris et al. [
1] analyzed data from studies that enrolled patients with AF duration up to 24 h, 48 h, 72 h, and 7 days. Indeed, the NMA generated some effect estimates with narrow confidence intervals but at a cost: potential network intransitivity and confidence in those estimates. …